Yaron Rotman
Affiliations: | NIDDK, Bethesda, MD, United States |
Area:
Liver Disease, NAFLD, GeneticsGoogle:
"Yaron Rotman"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Velenosi TJ, Ben-Yakov G, Podszun MC, et al. (2022) Postprandial plasma lipidomics reveal specific alteration of hepatic-derived diacylglycerols in non-alcoholic fatty liver disease. Gastroenterology |
| Hercun J, Kim GE, Da BL, et al. (2021) Durable virological response and functional cure of chronic hepatitis D after long-term peginterferon therapy. Alimentary Pharmacology & Therapeutics |
| Wang H, Mehal W, Nagy LE, et al. (2020) Immunological mechanisms and therapeutic targets of fatty liver diseases. Cellular & Molecular Immunology |
| Podszun MC, Alawad AS, Lingala S, et al. (2020) Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis. Redox Biology. 37: 101710 |
| Podszun MC, Chung JY, Ylaya K, et al. (2020) 4-HNE Immunohistochemistry and Image Analysis for Detection of Lipid Peroxidation in Human Liver Samples Using Vitamin E Treatment in NAFLD as a Proof of Concept. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 68: 635-643 |
| Ma Y, Brown PM, Lin DD, et al. (2020) Hsd17b13 Deficiency Does not Protect Mice From Obesogenic Diet Injury. Hepatology (Baltimore, Md.) |
| Suresh RR, Jain S, Chen Z, et al. (2020) Design and in vivo activity of A adenosine receptor agonist prodrugs. Purinergic Signalling |
| Han MAT, Vipani A, Noureddin N, et al. (2020) MR Elastography-Based Liver Fibrosis Correlates with Liver Events in Nonalcoholic Fatty Liver Patients: A Multi-Center Study. Liver International : Official Journal of the International Association For the Study of the Liver |
| Pfeiffer RM, Rotman Y, O'Brien TR. (2020) Genetic Determinants of Cirrhosis and Hepatocellular Carcinoma Due to Fatty Liver Disease: What's the Score? Hepatology (Baltimore, Md.) |
| Rotman Y, Kapuria D. (2020) Non‐alcoholic Fatty Liver Disease: Mechanisms and Treatment Liver. 670-681 |